Ignyta Completes Merger and Announces License Agreement for the Development of Two Leading Tyrosine Kinase Inhibitors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (OTCBB:IGASD), an oncology precision medicine biotechnology company, announced today its successful completion of a reverse merger with Infinity Oil & Gas Company. The combined company will focus solely on the business of Ignyta. The reverse merger was effected on October 31, 2013. Beginning November 1, 2013, Ignyta will trade under the symbol “IGASD” on the OTCBB until on or about December 2, 2013, when it will begin to be quoted under the symbol “RXDX” on the OTCBB.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC